<DOC>
	<DOC>NCT00927979</DOC>
	<brief_summary>In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecologic laparoscopic surgery. This is a second steady with protocol of general anesthesia used of Remifentanil.</brief_summary>
	<brief_title>Pain Relief by Intra-Peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia for Gynecological Laparoscopy</brief_title>
	<detailed_description>Outcome Measures : - VAS score - Use of analgesics during operation and postoperative period</detailed_description>
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>Elective gynecological laparoscopic surgery including unilateral or bilateral salpingooophorectomy or ovarian cystectomy Patient not participating in other medical study at present or during the last 30 days Patient is capable of reading, understanding and signing on an informed consent Age 18 years and above ASA physical status grade 12 Allergy to ropivacaine or other local anesthetics or other medications listed in the protocol Acute pelvic inflammatory disease Coumadin or aspirin treatment Significant arrythmias Analgesic treatment for chronic pain BMI&gt;35</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>